Generex Biotechnology Co. (OTCMKTS:GNBT) shares passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $1.82 and traded as high as $2.17. Generex Biotechnology shares last traded at $2.17, with a volume of 33,622 shares traded.
Separately, ValuEngine cut shares of Generex Biotechnology from a “buy” rating to a “hold” rating in a report on Tuesday, July 2nd.
The firm’s fifty day simple moving average is $2.65 and its 200 day simple moving average is $1.82.
About Generex Biotechnology (OTCMKTS:GNBT)
Generex Biotechnology Corporation, through its subsidiaries, primarily engages in the administration of formulations of large molecule drugs to the oral cavity using a hand-held aerosol applicator in Canada and the United States. It offers Generex Oral-lyn, an insulin formulation administered as a fine spray into the oral cavity.
Featured Article: What is required to own or exchange cryptocurrency?
Receive News & Ratings for Generex Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Generex Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.